Synonyms: Compound A [WO2022119905A2]
Compound class:
Synthetic organic
Comment: Uplarafenib is the INN for a BRAF inhibitor that was designed as an antineoplastic agent. It is one of the compounds claimed in patent WO2022119905A2 (NeuPharma) [1]. Uplarafenib is likely Henlius/NeuPharma lead BRAF asset HLX208 (RX208), that is designed to target oncogenic BRAFV600E.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[2,4,5-trifluoro-3-(3-morpholin-4-ylquinoxaline-6-carbonyl)phenyl]propane-1-sulfonamide |
Synonyms |
Compound A [WO2022119905A2] |
Database Links | |
CAS Registry No. | 1425485-87-5 (source: WHO INN record) |
GtoPdb PubChem SID | 485206003 |
PubChem CID | 71506198 |
Search Google for chemical match using the InChIKey | HAYBWDINAFTFCJ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | HAYBWDINAFTFCJ |
UniChem Compound Search for chemical match using the InChIKey | HAYBWDINAFTFCJ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HAYBWDINAFTFCJ-UHFFFAOYSA-N |